PMC:7558233 / 30882-31198 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"778","span":{"begin":162,"end":172},"obj":"Chemical"},{"id":"797","span":{"begin":252,"end":261},"obj":"Disease"}],"attributes":[{"id":"A778","pred":"tao:has_database_id","subj":"778","obj":"MESH:C000606551"},{"id":"A797","pred":"tao:has_database_id","subj":"797","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Both trials indicated a numerically faster time to clinical improvement in the treatment group [82], [85] and, in a more recent clinical trial, administration of remdesivir for 10 d was associated with a faster time to clinical improvement and a lower mortality rate by 14 d, as compared with the placebo group [86]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T186","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Both trials indicated a numerically faster time to clinical improvement in the treatment group [82], [85] and, in a more recent clinical trial, administration of remdesivir for 10 d was associated with a faster time to clinical improvement and a lower mortality rate by 14 d, as compared with the placebo group [86]."}

{"project":"MyTest","denotations":[{"id":"33078078-32187464-28132416","span":{"begin":96,"end":98},"obj":"32187464"},{"id":"33078078-32423584-28132417","span":{"begin":102,"end":104},"obj":"32423584"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Both trials indicated a numerically faster time to clinical improvement in the treatment group [82], [85] and, in a more recent clinical trial, administration of remdesivir for 10 d was associated with a faster time to clinical improvement and a lower mortality rate by 14 d, as compared with the placebo group [86]."}

{"project":"2_test","denotations":[{"id":"33078078-32187464-28132416","span":{"begin":96,"end":98},"obj":"32187464"},{"id":"33078078-32423584-28132417","span":{"begin":102,"end":104},"obj":"32423584"}],"text":"Both trials indicated a numerically faster time to clinical improvement in the treatment group [82], [85] and, in a more recent clinical trial, administration of remdesivir for 10 d was associated with a faster time to clinical improvement and a lower mortality rate by 14 d, as compared with the placebo group [86]."}